ATE392429T1 - Lebend-impfstoff gegen heliobacter pylori - Google Patents
Lebend-impfstoff gegen heliobacter pyloriInfo
- Publication number
- ATE392429T1 ATE392429T1 AT97940148T AT97940148T ATE392429T1 AT E392429 T1 ATE392429 T1 AT E392429T1 AT 97940148 T AT97940148 T AT 97940148T AT 97940148 T AT97940148 T AT 97940148T AT E392429 T1 ATE392429 T1 AT E392429T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine against
- live vaccine
- heliobacter pylori
- pylori
- against heliobacter
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000590002 Helicobacter pylori Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940037467 helicobacter pylori Drugs 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96116337A EP0835928A1 (de) | 1996-10-11 | 1996-10-11 | Helicobacter Pylori Lebendimpfstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE392429T1 true ATE392429T1 (de) | 2008-05-15 |
Family
ID=8223286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97940148T ATE392429T1 (de) | 1996-10-11 | 1997-09-01 | Lebend-impfstoff gegen heliobacter pylori |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0835928A1 (de) |
| JP (1) | JP2001510986A (de) |
| KR (1) | KR100510928B1 (de) |
| CN (1) | CN1215167C (de) |
| AT (1) | ATE392429T1 (de) |
| AU (1) | AU734635B2 (de) |
| BR (1) | BR9713254A (de) |
| CA (1) | CA2268033A1 (de) |
| DE (1) | DE69738641D1 (de) |
| IL (1) | IL129366A0 (de) |
| NO (1) | NO991692L (de) |
| NZ (1) | NZ335050A (de) |
| PL (1) | PL332575A1 (de) |
| TR (1) | TR199901450T2 (de) |
| WO (1) | WO1998016552A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248551B1 (en) * | 1997-03-28 | 2001-06-19 | Institut Pasteur | Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
| US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
| CA2335487A1 (en) * | 1998-06-19 | 1999-12-23 | Merieux Oravax | Lt and ct in parenteral immunization methods against helicobacter infection |
| AU8464398A (en) * | 1998-07-16 | 2000-02-07 | Cheil Jedang Corporation | Urease based vaccine against (helicobacter) infection |
| EP1278768B1 (de) * | 2000-04-27 | 2006-11-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methode zur identifizierung von helicobacter antigenen |
| RU2593953C2 (ru) * | 2010-12-22 | 2016-08-10 | Интервет Интернэшнл Бв | Вакцины с живыми бактериальными изолятами для системного введения |
| EP2697386B1 (de) | 2011-04-08 | 2017-11-01 | Tufts Medical Center, Inc. | Pepducin-entwurf und -verwendung |
| WO2017083618A1 (en) | 2015-11-13 | 2017-05-18 | Oasis Pharmaceuticals, LLC | Protease-activated receptor-2 modulators |
| CN112048008B (zh) * | 2020-08-12 | 2021-06-15 | 河北医科大学第四医院（河北省肿瘤医院） | 一种幽门螺杆菌b细胞耐受表位及其制备的抗体 |
| CN112143741B (zh) * | 2020-09-07 | 2022-09-20 | 中国科学院南海海洋研究所 | 一种生物膜基因岛GIVal43097及其切除方法 |
| CN112190704B (zh) * | 2020-10-13 | 2022-11-15 | 宁夏医科大学 | M细胞靶向性重组乳酸菌疫苗及制备方法与应用 |
| CN112143750B (zh) * | 2020-10-13 | 2022-12-27 | 宁夏医科大学 | 靶向m细胞的重组乳酸菌表面展示系统、重组乳酸菌疫苗及制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5695983A (en) * | 1990-12-18 | 1997-12-09 | The General Hospital Corporation | Salmonella vaccines |
| DE4041045A1 (de) * | 1990-12-20 | 1992-07-02 | Max Planck Gesellschaft | Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen |
| FR2682122B1 (fr) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori. |
| US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
| WO1995014093A1 (en) * | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| EP0654273A1 (de) * | 1993-11-18 | 1995-05-24 | Harry H. Leveen | Pharmazeutisches Produkt und Behandlungsverfahren |
| AU5523196A (en) * | 1995-02-27 | 1996-09-18 | Enteron Limited Partnership | Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms |
| CA2219201A1 (en) * | 1995-04-28 | 1996-10-31 | Oravax, Inc. | Multimeric, recombinant urease vaccine |
-
1996
- 1996-10-11 EP EP96116337A patent/EP0835928A1/de not_active Withdrawn
-
1997
- 1997-09-01 JP JP51794498A patent/JP2001510986A/ja not_active Ceased
- 1997-09-01 IL IL12936697A patent/IL129366A0/xx unknown
- 1997-09-01 BR BR9713254-3A patent/BR9713254A/pt not_active Application Discontinuation
- 1997-09-01 DE DE69738641T patent/DE69738641D1/de not_active Expired - Lifetime
- 1997-09-01 KR KR10-1999-7003168A patent/KR100510928B1/ko not_active IP Right Cessation
- 1997-09-01 WO PCT/EP1997/004744 patent/WO1998016552A1/en active IP Right Grant
- 1997-09-01 TR TR1999/01450T patent/TR199901450T2/xx unknown
- 1997-09-01 NZ NZ335050A patent/NZ335050A/xx unknown
- 1997-09-01 AT AT97940148T patent/ATE392429T1/de not_active IP Right Cessation
- 1997-09-01 CN CNB971995516A patent/CN1215167C/zh not_active Expired - Fee Related
- 1997-09-01 EP EP97940148A patent/EP0931093B1/de not_active Expired - Lifetime
- 1997-09-01 AU AU42084/97A patent/AU734635B2/en not_active Ceased
- 1997-09-01 CA CA002268033A patent/CA2268033A1/en not_active Abandoned
- 1997-09-01 PL PL97332575A patent/PL332575A1/xx not_active IP Right Cessation
-
1999
- 1999-04-09 NO NO991692A patent/NO991692L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1215167C (zh) | 2005-08-17 |
| WO1998016552A1 (en) | 1998-04-23 |
| NO991692L (no) | 1999-06-04 |
| KR20000049090A (ko) | 2000-07-25 |
| BR9713254A (pt) | 1999-11-03 |
| JP2001510986A (ja) | 2001-08-07 |
| AU4208497A (en) | 1998-05-11 |
| EP0931093B1 (de) | 2008-04-16 |
| CN1246867A (zh) | 2000-03-08 |
| NO991692D0 (no) | 1999-04-09 |
| EP0931093A1 (de) | 1999-07-28 |
| AU734635B2 (en) | 2001-06-21 |
| PL332575A1 (en) | 1999-09-27 |
| TR199901450T2 (xx) | 1999-10-21 |
| EP0835928A1 (de) | 1998-04-15 |
| KR100510928B1 (ko) | 2005-08-31 |
| DE69738641D1 (de) | 2008-05-29 |
| CA2268033A1 (en) | 1998-04-23 |
| IL129366A0 (en) | 2000-02-17 |
| NZ335050A (en) | 2000-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2303854B (en) | Helicobacter proteins and vaccines | |
| PL304419A1 (en) | Urease based vaccine against heliobacter infections | |
| DK0835930T3 (da) | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) | |
| ATE392429T1 (de) | Lebend-impfstoff gegen heliobacter pylori | |
| DK0639640T3 (da) | Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91 | |
| DK0745387T3 (da) | Adjuvanser til virale vacciner | |
| NZ314585A (en) | Method of treating H. Pylori associated gastroduodenal disease | |
| ATE377428T1 (de) | Rotavirus-impfstoff | |
| HU9701586D0 (en) | Improved inactivated vaccines | |
| SE9604322D0 (sv) | Bacterial antigens and vaccine compositions II | |
| GB9818133D0 (en) | Vaccine | |
| DK0975360T3 (da) | Bovint respiratorisk og enterisk coronavirus som vaccine | |
| DE69331459T2 (de) | Parenterale immunisierung gegen rotavirus | |
| DE69513760T2 (de) | Auf Helicobacter pylori Katalase basierende immunisierende Zusammensetzung | |
| DE69130953T2 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
| SE9702240D0 (sv) | Vaccine compositions III | |
| MX9700215A (es) | Proteinas y vacunas de helicobacter. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |